Drawing for SERVIER

USPTO serial 79364527

SERVIER

Reviewed by CopyMark Law Group

Reg. 7656296Status 700Registered
Filing date
Status date
Registration date
Jan 21, 2025
Examiner
STURMAN, MELISSA M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SERVIER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for preventing and treating disorders of the central nervous system, cytostatic pharmaceutical preparations for use in the treatment of cancer, pharmaceutical preparations for preventing and treating metabolism disorders, pharmaceutical preparations for the treatment and prevention of obesity, pharmaceutical preparations for the treatment and prevention of diabetes, pharmaceutical preparations for treating blood and blood forming organs to aid in blood clotting, pharmaceutical preparations for the treatment and prevention of disorders of the respiratory system, pharmaceutical preparations for the treatment and prevention of disorders of the musculo-skeletal system, pharmaceutical preparations for the treatment and prevention of disorders of the genitourinary system, anti-infective pharmaceutical preparations, pharmaceutical preparations for the treatment and prevention of disorders of the ophthalmological systemACTIVE—
009Scientific, optical, weighing, measuring, signaling, checking, inspecting, life-saving and teaching apparatus and instruments, namely, computers and microscopes; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity, namely, electric current transformers, electrical power distribution units; apparatus for sound or image recording, transmission and reproduction; magnetic recording media, namely, blank magnetic disks; data and data information processing apparatus and equipment, namely, couplers; sound recording disks, namely, blank audio discs; digital recording media, namely, blank magnetic disks; data and data information processing apparatus and equipment; software, namely, downloadable software for processing digital images of the anatomy for diagnostic and treatment; downloadable computer programs for managing electronic data and databases, database administration, managing cloud applications, and self-automation of database-management activities; computers; software recorded on magnetic media or downloaded from a remote computer network for the analysis, storage and monitoring of medical data; downloadable computer software applications for providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; telecommunication equipment for use with mobile networks, namely, telecommunication exchangers, telecommunications transmitters; personal digital assistant; electronic signal transmitters; connected bracelets being measuring instruments, namely, wearable activity trackers; connected scales being electronic scales; connected watches as measuring instruments, namely, smart watches; video cameras; electronic proximity sensors; downloadable mobile applications for providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; digital applications, namely, downloadable mobile applications for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; software incorporating algorithms, namely, downloadable computer software for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; artificial intelligence software, namely, downloadable computer software using artificial intelligence for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable computer software platforms in the form of information sharing software for providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; connected self-measurement instruments being scales; encoded electronic chip cards connected to an information system containing programming used for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable applications for mobile devices for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; spectacles; contact lenses; smart glasses; in-ear headphones; downloadable telemedicine applications for mobile devices; downloadable augmented reality software for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable virtual reality computer programs for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; analysis systems based on artificial intelligence, namely, downloadable computer software using artificial intelligence for assisting with patient diagnosis, providing surveillance of patient health data, and providing prevention and treatment information in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; medical image analysis systems based on artificial intelligence, namely, downloadable computer software using artificial intelligence for medical imaging; virtual reality headsetsACTIVE—
010Medical, surgical, dental and veterinary apparatus, instruments and equipment for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; artificial limbs, organs being artificial hearts, eyes and teeth; orthopedic articles, namely, orthopedic braces, orthopedic belts; surgical instruments for use in orthopedic surgery; medical, surgical and orthopedic implants made of artificial materials; suture materials; compression stockings, tights and socks; stockings, tights and socks for varicose veins; bandages for compression dressing; medical apparatus, instruments and equipment for introducing pharmaceutical preparations into the human body, particularly for prolonged, controlled or immediate release of active substances; infusion devices for administering drugs and syringes for medical use; medical measuring instruments, in particular instruments able to directly transmit data to a database, in particular instruments to measure fevers, heart rate monitors; apparatus, instruments and equipment derived from robotics for medical use, namely, surgical robots; nanobots for medical use in the nature of surgical robots; apparatus, instruments and equipment derived from bionics for medical use for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; medical devices, namely, connected materials for medical use in the nature of suture materials; medical devices, namely, smart materials for medical use in the nature of implants consisting primarily of artificial materials and also including biological materials; medical diagnostic apparatus for allergy tests; blood testing apparatus; medical devices intended for ingestion, namely, endoscopy camera for medical purposes; endoscopic equipment for medical purposes in the nature of video capsules; medical apparatus for measuring biochemical changes in blood; blood biomarker devices in the nature of blood testing apparatus; medical endoscopy apparatus, namely, medical instruments for use in endoscopy procedures; inhalers for medical purposes, sold empty; blood pressure monitors; physiological monitoring and measuring apparatus for medical use, namely, for measuring and monitoring blood pressure, lung capacity for use in the field of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; telemetry apparatus for medical use; acupuncture instruments; hearing aids; automatic analyzers for medical use, namely, hematology analyzers for medical diagnostic uses; medical imaging apparatus; massage apparatusACTIVE—
042Scientific and technological services as well as research and design services relating thereto, namely, scientific research, technological research, and new product design services in the fields of pharmaceuticals and bio-chemicals for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; industrial analysis and research services, namely, industrial research in the fields of pharmaceuticals and bio-chemicals for the prevention and treatment of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; scientific research services for medical research purposes; design and development of computer hardware and software; research, design and development of new products for others, namely, medical tools for monitoring, diagnosis, prediction, analysis; medical and scientific research, namely, conducting clinical trials for others; scientific laboratory services; evaluation, scientific and technical project studies in the nature of technical research in the field of pharmaceutical studies; providing virtual computer systems through cloud computing; rental of computer software for medical research and collaboration; updating of computer software; programming for computers; research and development of new products for third parties; electronic data storage; hosting platforms on the Internet, hosting of web sites; temporary provision of non-downloadable software applications accessible via an Internet site, namely, providing temporary use of a web-based software application for medical research and collaboration; web site design services on the Internet, especially collaborative platforms; engineering design services relating to robotics; development of software directed at patientsACTIVE—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; advice with respect to health, namely, advisory services relating to heath; consultation with respect to pharmacy, namely, pharmaceutical consultation; health services, namely, healthcare; telemedicine services; therapeutic services, namely, physical therapy; medical diagnosis of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; home health care care services; individualized medical prescription services, namely, preparation of prescriptions by pharmacists; online medical prescription services, namely, preparation of prescriptions by pharmacists; providing support in the monitoring of patients receiving medical treatment, namely, remote monitoring of medical data for medical diagnosis and treatment; consultancy in relation to medical treatment in the home; consultancy regarding self-medication; medical information services for patients; remote medical examination services; advice concerning personal well-being in the nature of advisory services relating to health; medical monitoring of patients including provided remotely for medical diagnosis and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 22, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 31, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 31, 2025FIMPFINAL DISPOSITION PROCESSED—
Apr 21, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 21, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 21, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 3, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 3, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2024RFNTREFUSAL PROCESSED BY IB—
Sep 14, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 5, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 5, 2024RFRRREFUSAL PROCESSED BY MPU—
Sep 5, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2024RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Aug 7, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 7, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 13, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 12, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2023DOCKASSIGNED TO EXAMINER—
Mar 14, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance